BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37070378)

  • 1. Anti-fibrinolytic agent tranexamic acid suppresses the endotoxin-induced expression of Tnfα and Il1α genes in a plasmin-independent manner.
    Kacer D; Machnitzky E; Fung A; Greene A; Carter D; Rappold J; Prudovsky I
    Transfusion; 2023 May; 63 Suppl 3():S168-S176. PubMed ID: 37070378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid: Beyond antifibrinolysis.
    Prudovsky I; Kacer D; Zucco VV; Palmeri M; Falank C; Kramer R; Carter D; Rappold J
    Transfusion; 2022 Aug; 62 Suppl 1():S301-S312. PubMed ID: 35834488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.
    Draxler DF; Daglas M; Fernando A; Hanafi G; McCutcheon F; Ho H; Galle A; Gregory J; Larsson P; Keragala C; Wright DK; Tavancheh E; Au AE; Niego B; Wilson K; Plebanski M; Sashindranath M; Medcalf RL
    J Thromb Haemost; 2019 Dec; 17(12):2174-2187. PubMed ID: 31393041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-dependent effects of tranexamic acid on blood-brain barrier permeability and the immune response following traumatic brain injury in mice.
    Daglas M; Galle A; Draxler DF; Ho H; Liu Z; Sashindranath M; Medcalf RL
    J Thromb Haemost; 2020 Oct; 18(10):2658-2671. PubMed ID: 32668057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
    Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
    Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
    J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.
    Miszta A; Ahmadzia HK; Luban NLC; Li S; Guo D; Holle LA; Berger JS; James AH; Gobburu JVS; van den Anker J; de Laat B; Wolberg AS
    J Thromb Haemost; 2021 Jan; 19(1):221-232. PubMed ID: 33001565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic Acid Influences the Immune Response, but not Bacterial Clearance in a Model of Post-Traumatic Brain Injury Pneumonia.
    Draxler DF; Awad MM; Hanafi G; Daglas M; Ho H; Keragala C; Galle A; Roquilly A; Lyras D; Sashindranath M; Medcalf RL
    J Neurotrauma; 2019 Dec; 36(23):3297-3308. PubMed ID: 31140372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tranexamic acid administration on acute traumatic coagulopathy in rats with polytrauma and hemorrhage.
    Wu X; Benov A; Darlington DN; Keesee JD; Liu B; Cap AP
    PLoS One; 2019; 14(10):e0223406. PubMed ID: 31581265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tranexamic acid on the conversion of Glu-plasminogen I and II to its Lys-forms.
    Takada A; Takada Y
    Thromb Res; 1985 Oct; 40(2):171-9. PubMed ID: 2933845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Anastomotic Leak Via Local Application of Tranexamic Acid to Target Bacterial-mediated Plasminogen Activation: A Practical Solution to a Complex Problem.
    Jacobson RA; Williamson AJ; Wienholts K; Gaines S; Hyoju S; van Goor H; Zaborin A; Shogan BD; Zaborina O; Alverdy JC
    Ann Surg; 2021 Dec; 274(6):e1038-e1046. PubMed ID: 31851007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporally and regionally disparate differences in plasmin activity by tranexamic acid.
    Reust DL; Reeves ST; Abernathy JH; Dixon JA; Gaillard WF; Mukherjee R; Koval CN; Stroud RE; Spinale FG
    Anesth Analg; 2010 Mar; 110(3):694-701. PubMed ID: 20185649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic acid modulates the immune response and reduces postsurgical infection rates.
    Draxler DF; Yep K; Hanafi G; Winton A; Daglas M; Ho H; Sashindranath M; Wutzlhofer LM; Forbes A; Goncalves I; Tran HA; Wallace S; Plebanski M; Myles PS; Medcalf RL
    Blood Adv; 2019 May; 3(10):1598-1609. PubMed ID: 31126915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia.
    Ilich A; Gernsheimer TB; Triulzi DJ; Herren H; Brown SP; Holle LA; Lucas AT; de Laat B; El Kassar N; Wolberg AS; May S; Key NS
    Blood Adv; 2023 Mar; 7(6):900-908. PubMed ID: 36044391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid: less bleeding and less thrombosis?
    Godier A; Roberts I; Hunt BJ
    Crit Care; 2012 Jun; 16(3):135. PubMed ID: 22748073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid prolongs survival after controlled hemorrhage in rats.
    Roy M; Burggraf M; Lendemans S; de Groot H; Rohrig R
    J Surg Res; 2017 Feb; 208():104-110. PubMed ID: 27993197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.